← back to search

Peter G. Middleton

The University of Sydney · AU
Area of research
Pulmonary and Respiratory Medicine · Hematology
Research interest
Research interests include Cystic Fibrosis Research Advances, Neonatal Respiratory Health Research, Hematopoietic Stem Cell Transplantation, and Tracheal and airway disorders.
h-index
48
citations
8,937
works
247
NIH funding
primary concept
email

Recent publications

Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with Biologics
American Journal of Respiratory and Critical Care Medicine 2025cited by 15position: middledoi
Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues
Journal of Cystic Fibrosis 2024cited by 74position: lastdoi
Standards for the care of people with cystic fibrosis (CF); Planning for a longer life
Journal of Cystic Fibrosis 2024cited by 30position: middledoi
ECFS standards of care on CFTR-related disorders: Identification and care of the disorders
Journal of Cystic Fibrosis 2024cited by 28position: middledoi
Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
Journal of Cystic Fibrosis 2024cited by 7position: middledoi
Standards for the care of people with cystic fibrosis; establishing and maintaining health
Journal of Cystic Fibrosis 2023cited by 79position: middledoi
Standards for the care of people with cystic fibrosis (CF): A timely and accurate diagnosis
Journal of Cystic Fibrosis 2023cited by 27position: middledoi
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study
Journal of Cystic Fibrosis 2022cited by 28position: middledoi
Defining a Severe Asthma Super-Responder: Findings from a Delphi Process
The Journal of Allergy and Clinical Immunology In Practice 2021cited by 144position: middledoi
Outcomes of pregnancy in women with cystic fibrosis (CF) taking CFTR modulators – an international survey
Journal of Cystic Fibrosis 2020cited by 93position: middledoi
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
Journal of Cystic Fibrosis 2020cited by 90position: middledoi
Development of elexacaftor – tezacaftor – ivacaftor: Highly effective CFTR modulation for the majority of people with Cystic Fibrosis
Expert Review of Respiratory Medicine 2020cited by 48position: firstdoi
Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
New England Journal of Medicine 2019cited by 2,078position: firstdoi
ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases
European Respiratory Journal 2019cited by 128position: firstdoi
Australian adults with bronchiectasis: The first report from the Australian Bronchiectasis Registry
Respiratory Medicine 2019cited by 95position: middledoi
Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven?
Lung 2019cited by 45position: middledoi
Treatable traits can be identified in a severe asthma registry and predict future exacerbations
Respirology 2018cited by 181position: middledoi
Working while unwell: Workplace impairment in people with severe asthma
Clinical & Experimental Allergy 2018cited by 80position: middledoi
Validation of the Sonomat: A Contactless Monitoring System Used for the Diagnosis of Sleep Disordered Breathing
SLEEP 2014cited by 79position: middledoi
Nasal potential difference measurements in diagnosis of cystic fibrosis: An international survey
Journal of Cystic Fibrosis 2013cited by 43position: middledoi
CFTR biomarkers: time for promotion to surrogate end-point
European Respiratory Journal 2012cited by 107position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jennifer L. Taylor‐Cousar · National Jewish Health3 papers (2019–2020)Greg J. Fox · Macquarie University2 papers (2019–2019)Warwick J. Britton · The University of Sydney2 papers (2019–2019) · 2 papers (2019–2023) · 2 papers (2019–2019) · 2 papers (2019–2019)Paul T. King · Monash University2 papers (2019–2019)S. Visser · The University of Sydney2 papers (2019–2019)Daniel J. Smith · Georgetown University2 papers (2019–2019)Peter T.P. Bye · The University of Sydney2 papers (2019–2019) · 2 papers (2019–2019)Lucy Morgan · The University of Sydney2 papers (2019–2019)Lucy Burr · University of Queensland2 papers (2019–2019)Rachel Thomson · University of Queensland2 papers (2019–2019)F. Vermeulen · KU Leuven2 papers (2013–2019)Anne B. Chang · Albany Medical Center Hospital2 papers (2019–2019)Marcus Mall · Ludwig-Maximilians-Universität München1 papers (2019–2019) · 1 papers (2023–2023)Kevin W Southern · University of Liverpool1 papers (2023–2023)C. Addy · Cambridge University Hospitals NHS Foundation Trust1 papers (2023–2023)